HALISTER1: Thermo Fisher Rises as Cleveland Upgrades on Upside Potential

Thermo Fisher Rises as Cleveland Upgrades on Upside Potential

(Bloomberg) -- Thermo Fisher Scientific rises as much as 1.5%, touching a new record high, after Cleveland Research analyst Steve Willoughby raised to buy from neutral, PT $206, seeing upside from improving fundamentals.
  • Says demand from pharma customers has remained strong while demand from industrial and academic customers appears to be improving; trends likely continued in 2Q
  • Sees upside potential to co.’s 4% 2017 organic growth guidance
  • TMO has 15 buys, 2 holds, no sells, avg PT $193: Bloomberg
  • Shares rose 29% this year while S&P 500 Health index is up 17%
To contact the reporter on this story: Tatiana Darie in New York at tdarie1@bloomberg.net To contact the editors responsible for this story: Arie Shapira at ashapira3@bloomberg.net Will Daley

Alert: HALISTER1
Source: BFW (Bloomberg First Word)

Tickers
TMO US (Thermo Fisher Scientific Inc)

People
Steve Willoughby (Cleveland Research Co)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283